HIV/AIDS in Prisons: A Review of the International Evidence - Ralf Jurgens

15
Winnipeg, 23 November 2009 1 | HIV/AIDS in prisons: A review of the international evidence Winnipeg, 23 November 2009 Ralf Jürgens, consultant

description

Presentation made by Ralf Jurgens, an international expert in HIV/AIDS in prisons, at the University of Winnipeg, November 23, 2009. The presentation was a part of a panel discussion on Prisoners' Rights to HIV Prevention, Treatment and Care, along with Richard Elliott and Jim Motherall. Dr. Michael Eze, Director of the Global College Institute for Health and Human Potential provided a response to the panel, and the evening concluded with Q&A from the audience.See also the presentation by Richard Elliott: "Clean Switch: The Case for Prison-based Needle and Syringe Programs"

Transcript of HIV/AIDS in Prisons: A Review of the International Evidence - Ralf Jurgens

Page 1: HIV/AIDS in Prisons: A Review of the International Evidence - Ralf Jurgens

Winnipeg, 23 November 20091 |

HIV/AIDS in prisons: A review of the international evidence

HIV/AIDS in prisons: A review of the international evidence

Winnipeg, 23 November 2009

Ralf Jürgens, consultant

Page 2: HIV/AIDS in Prisons: A Review of the International Evidence - Ralf Jurgens

Winnipeg, 23 November 20092 |

AcknowledgementsAcknowledgements

Annette Verster & Andrew Ball (WHO)

Peer reviewers

UNODC, UNAIDS

Page 3: HIV/AIDS in Prisons: A Review of the International Evidence - Ralf Jurgens

Winnipeg, 23 November 20093 |

BackgroundBackground

High rates of HIV in prisons

Hepatitis C rates even higher

Risk behaviours are prevalent in prisons

Outbreaks of HIV in prisons have been documented

High turnover of populationsSources: Dolan et al., 2007, Macalino et al., 2004, Dolan & Wodak, 1999; MacDonald, 2005; Bobrik et al.,

2005; Taylor et al., 1995

Page 4: HIV/AIDS in Prisons: A Review of the International Evidence - Ralf Jurgens

Winnipeg, 23 November 20094 |

BackgroundBackground

Drugs can and do enter into prisons

Many prisoners are in prison because of offences related to drugs – people who use drugs outside often find a way to use inside

Other prisoners start using (and/or injecting) drugs in prison

Page 5: HIV/AIDS in Prisons: A Review of the International Evidence - Ralf Jurgens

Winnipeg, 23 November 20095 |

HIV prevalence in selected countriesHIV prevalence in selected countries

0.3-1.6% 3.2-20% Brazil

0.8-4.3% 16-32% (5 regions) Ukraine

0.1-0.2% 4-22% Indonesia

0.3-0.9% 28.4% Viet Nam

0.7-1.8% Up to 4% Russian Federation

0.4-1.0% Up to 14% Spain

0.3% 0.6-7% Mexico

0.4-1.0% 1.9% USA

0.2-0.5% 1-12% Canada

Est. Adult HIV Prevalence 2005

HIV Prevalence in Prisons

Country

Page 6: HIV/AIDS in Prisons: A Review of the International Evidence - Ralf Jurgens

Winnipeg, 23 November 20096 |

Injecting & needle sharing in prison Injecting & needle sharing in prison

0102030405060708090

100

Au

stralia Lo

w

Au

stralia hig

h

Can

ada

En

glan

d

Greece

RF

Th

ailand

% sharing

010

2030

4050

60

7080

Au

stralia low

Au

stralia hig

h

Can

ada lo

w

Can

ada h

igh

En

glan

d

Greece

Mau

ritius

Mau

ritius h

igh

RF

low

RF

hig

h

Th

ailand

US

A

% injecting

Page 7: HIV/AIDS in Prisons: A Review of the International Evidence - Ralf Jurgens

Winnipeg, 23 November 20097 |

Review of the evidenceReview of the evidence

WHO, UNAIDS, UNODC commissioned review:

evidence regarding all interventions that are part of a comprehensive approach to HIV in prison

English & Russian version of all papers:

www.who.int/hiv/topics/idu/prisons/en/

Page 8: HIV/AIDS in Prisons: A Review of the International Evidence - Ralf Jurgens

Winnipeg, 23 November 20098 |

Education and informationEducation and information

Information & education programs result in increased knowledge (eg, Vaz, Gloyd & Trindade, 1996)

However, evidence of effect of increased knowledge on behaviour is limited (Braithwaite, Hammett & Mayberry, 1996)

Peer education is more effective (Grinstead et al, 1999)

Education is not enough

Page 9: HIV/AIDS in Prisons: A Review of the International Evidence - Ralf Jurgens

Winnipeg, 23 November 20099 |

Needle and syringe programmesNeedle and syringe programmes

First established in Switzerland in 1992

Since then, introduced in 12 countries in western and eastern Europe and central Asia

Several models for distribution: health care, automatic dispensing machines, peer outreach workers

Programs available in all types of prisons: small & large, single cell & barracks, low-, medium- and high-security, prisons for males & prisons for females, etc

Page 10: HIV/AIDS in Prisons: A Review of the International Evidence - Ralf Jurgens

Winnipeg, 23 November 200910 |

Evidence NSPsEvidence NSPs

PrisonIncidence HIV&HCV

Needle sharingDrug useInjecting

Am Hasenburg (D)No increaseNo increase

Basauri (Es)No HIVNo increaseNo increase

Hannoversand (D)No increaseNo increase

Hindelbank (CH)No HIVDecreaseNo increase

Lehrter Strasse & Lichtenburg (D)No HIV but HCVNo increaseNo increase

Linger 1 (D)No HIVNo increaseNo increase

Realta (CH)No HIVSingle casesDecreaseNo increase

Vechta (D)No HIVNo increaseNo increase

Vierlande (D)No HIVLittle change or reduction

No increaseNo increase

(Stöver & Nelles, 2003; Stark et al., 2005; Rutter et al., 2001)

Page 11: HIV/AIDS in Prisons: A Review of the International Evidence - Ralf Jurgens

Winnipeg, 23 November 200911 |

Evidence NSPs Evidence NSPs

No negative consequences– No increase in drug use or injecting– needles are not used as weapons

Increased referral to drug dependence treatment

Increased staff safety

Page 12: HIV/AIDS in Prisons: A Review of the International Evidence - Ralf Jurgens

Winnipeg, 23 November 200912 |

Recommendations NSPs Recommendations NSPs

WHO,UNODC, UNAIDS therefore recommend:

– Introduce NSPs urgently and expand to scale

– Easy and confidential access to NSPs

– Distribution through peers

Page 13: HIV/AIDS in Prisons: A Review of the International Evidence - Ralf Jurgens

Winnipeg, 23 November 200913 |

Bleach and decontamination strategiesBleach and decontamination strategies

Feasible and does not compromise securityDoubts about effectiveness

– Conditions in prisons reduce probability of effective decontamination

Bleach programmes cannot replace NSPsProvide information on limited effectivenessContinue efforts to introduce NSPs

Page 14: HIV/AIDS in Prisons: A Review of the International Evidence - Ralf Jurgens

Winnipeg, 23 November 200914 |

Drug demand & supply reduction measuresDrug demand & supply reduction measures

Some systems have vastly expanded drug interdiction measures (drug dogs, modern drug detection analysis, urinalysis, “drug-free units”, etc)

Drug use has remained highImproving documentation & evaluation of these

measures should be a priorityPrison systems with drug testing programs should

reconsider testing for cannabis.

Page 15: HIV/AIDS in Prisons: A Review of the International Evidence - Ralf Jurgens

Winnipeg, 23 November 200915 |

Conclusion: From evidence to actionConclusion: From evidence to action

“All prisoners have the right to receive health care, including preventive measures, equivalent to that available in the community” (WHO, 1993)

Time to move from evidence to action: Universal access to prevention & treatment is also needed for prisoners

For more info:

www.who.int/hiv/topics/idu/prisons/en/